PH Sensing

Overview

pH sensing refers to the molecular mechanisms by which bacteria detect and respond to changes in environmental acidity. In the gut — where pH ranges from ~2 in the stomach to ~7.4 in the distal ileum and ~5.5-7.0 in the colon — pH is a master regulator of metal bioavailability, microbial gene expression, and virulence factor production.

pH and Metal Bioavailability

pH directly controls the solubility and speciation of metals in the gut lumen. At acidic pH, iron (Fe2+/Fe3+), zinc, and nickel become more soluble and bioavailable. At neutral to alkaline pH, these metals precipitate or bind to organic ligands, reducing free concentrations. This means that pH-modifying organisms — urease producers like helicobacter pylori and morganella morganii — can effectively "unlock" metal resources by alkalinizing their local environment.

Bacterial pH-Sensing Systems

Bacteria employ several pH-sensing strategies. Two-component signal transduction systems (e.g., PhoP/PhoQ in Salmonella) detect periplasmic pH changes and activate acid tolerance or virulence programs. Acid fitness islands in E. coli encode glutamate and arginine decarboxylases that consume protons. Candida albicans uses pH sensing through the Rim101 pathway to switch between yeast and hyphal morphologies — a critical virulence transition.

Ecological Consequences

pH gradients create spatial niches within the gut. Butyrate-producing anaerobes like roseburia intestinalis lower local pH through fermentation, which paradoxically helps maintain colonization resistance by keeping iron less available to pathogens at mildly acidic colonic pH. When this pH buffering is lost — through antibiotic-mediated loss of fermenters — the resulting pH shift can cascade into altered metal availability and pathogen expansion.

Cross-References

References (8)

  1. Ghorbani M, Joseph GBS, Tew MM et al. (2024). Functional Associations of the Gut Microbiome with Dopamine, Serotonin, and BDNF in Schizophrenia: A Pilot Study. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. doi:10.1186/s41983-024-00901-0
  2. Patil, A., Gholap et al. (2021). Patil 2021 — Infection Metallomics in the COVID Era. Mass Spectrometry Reviews. doi:10.1002/mas.21755
  3. Saha S, Chant D, Welham J et al. (2005). A Systematic Review of the Prevalence of Schizophrenia. PLoS Medicine. doi:10.1371/journal.pmed.0020141
  4. Denise Mafra, Natalia A. Borges, Livia Alvarenga et al. (2022). Fermented Food: Should Patients with Cardiometabolic Diseases Go Back to an Early Neolithic Diet?. Critical Reviews in Food Science and Nutrition. doi:10.1080/10408398.2022.2077300
  5. Vasudevan Dinakaran, Andiappan Rathinavel, Muthuirulan Pushpanathan et al. (2014). Elevated Levels of Circulating DNA in Cardiovascular Disease Patients: Metagenomic Profiling of Microbiome in the Circulation. PLOS ONE. doi:10.1371/journal.pone.0105221
  6. Roberto Cilia, Emanuele Cereda, Valentina Ferri et al. (2020). Cilia 2020 -- Microbiome-Gut-Brain Axis and Dietary Interventions in Parkinson's Disease. CNS & Neurological Disorders - Drug Targets. doi:10.2174/1871527319666200729143555
  7. Yuanzhao Xu, Lingyue An, Jiling Xie et al. (2026). Xu 2026 — The Gut-Prostate Axis in Benign Prostatic Hyperplasia: Systematic Review of Microbial Dysbiosis and Pathogenic Mechanisms. BMC Urology. doi:10.1186/s12894-025-02003-2
  8. Qiang Luo, Yilan Hu, Xin Chen et al. (2022). Effects of Gut Microbiota and Metabolites on Heart Failure and Its Risk Factors: A Two-Sample Mendelian Randomization Study. Frontiers in Nutrition. doi:10.3389/fnut.2022.899746